BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1978509)

  • 1. New developments in the pathology of Parkinson's disease.
    Jellinger K
    Adv Neurol; 1990; 53():1-16. PubMed ID: 1978509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathological substrates of Alzheimer's disease and Parkinson's disease.
    Jellinger K
    J Neural Transm Suppl; 1987; 24():109-29. PubMed ID: 3316494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical and subcortical pathology in Parkinson's disease: relationship to parkinsonian dementia.
    Xuereb JH; Tomlinson BE; Irving D; Perry RH; Blessed G; Perry EK
    Adv Neurol; 1990; 53():35-40. PubMed ID: 2173374
    [No Abstract]   [Full Text] [Related]  

  • 4. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic Parkinson's disease: a review of clinical types and pathology.
    Olasode BJ
    Niger J Med; 2001; 10(3):116-20. PubMed ID: 11806009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia.
    Trojanowski JQ; Goedert M; Iwatsubo T; Lee VM
    Cell Death Differ; 1998 Oct; 5(10):832-7. PubMed ID: 10203692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathology of the cytoskeleton in Alzheimer's disease and disorders related to this disease].
    Seitelberg F; Lassmann H
    Gac Med Mex; 1990; 126(5):367-73. PubMed ID: 1966495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What causes mental dysfunction in Parkinson's disease?
    Emre M
    Mov Disord; 2003 Sep; 18 Suppl 6():S63-71. PubMed ID: 14502658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pathological study of the association between Lewy body disease and Alzheimer's disease.
    Gibb WR; Mann DM; Mountjoy CQ; Lees AJ
    Adv Neurol; 1990; 53():55-9. PubMed ID: 2173375
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathological basis for dementia in elderly patients with idiopathic Parkinson's disease.
    Yoshimura M
    Eur Neurol; 1988; 28 Suppl 1():29-35. PubMed ID: 3378559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The morphological basis of mental dysfunction in Parkinson's disease.
    Jellinger KA
    J Neurol Sci; 2006 Oct; 248(1-2):167-72. PubMed ID: 16797594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal loss in the substantia nigra in patients with Alzheimer's disease and Parkinson's disease in relation to extrapyramidal symptoms and dementia.
    Rinne JO; Rummukainen J; Paljärvi L; Säkö E; Mölsä P; Rinne UK
    Prog Clin Biol Res; 1989; 317():325-32. PubMed ID: 2602422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An autopsy case of Parkinson's disease associated clinically with dementia terminating in akinetic mutism and pathologically with multiple Lewy's Bodies in the cerebral cortex].
    Okeda R; Kayano T; Funata N; Kojima T; Miki M; Iwama H
    No To Shinkei; 1982 Aug; 34(8):761-7. PubMed ID: 6289855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease.
    Halliday GM; Macdonald V; Henderson JM
    Brain; 2005 Oct; 128(Pt 10):2272-80. PubMed ID: 16014651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A modern hypothesis: The distinct pathologies of dementia associated with Parkinson's disease versus Alzheimer's disease.
    Farlow MR; Cummings J
    Dement Geriatr Cogn Disord; 2008; 25(4):301-8. PubMed ID: 18311077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lewy bodies, a misleading marker for Parkinson's disease?].
    Duyckaerts C; Hauw JJ
    Bull Acad Natl Med; 2003; 187(2):277-92; discussion 292-3. PubMed ID: 14556441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease?
    Papapetropoulos S; Lieberman A; Gonzalez J; Mash DC
    Acta Neurol Scand; 2005 Jun; 111(6):353-9. PubMed ID: 15876335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal models of degenerative neurological disease.
    Cork LC; Kitt CA; Struble RG; Griffin JW; Price DL
    Prog Clin Biol Res; 1987; 229():241-69. PubMed ID: 3601987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
    Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurotransmitter anomalies in Alzheimer's disease].
    Berger B
    Rev Neurol (Paris); 1984; 140(10):539-52. PubMed ID: 6150545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.